Doctors treating Sen. John Fetterman (D-Pa.) at the George Washington University Hospital on Thursday released the results of an MRI — and other tests — ruling out a new stroke, his communications director Joe Calvello said in a statement.
Driving the news: Fetterman was hospitalized on Wednesday after he "began feeling lightheaded" during a Senate Democratic retreat in Washington, D.C.
More than two-thirds of health care providers are still using pandemic waivers and flexibilities that are due to expire when the COVID public health emergency ends in May, according to an analysis by the group purchasing organization Premier.
Why it matters: The health care system will undergo a major shift as hospitals, health systems and other providers lose special allowances on reporting requirements, patients' rights, virtual care and a host of other areas.
CVS Health's planned $10.6 billion purchase of Oak Street Health is the latest installment of a buying spree that's seen the pharmacy giant go deeper into delivering primary care — especially for seniors.
Why it matters: Absorbing a network of primary care centers focused on caring for Medicare patients helps CVS vie with other major retail and insurance giants that have been gobbling up providers.
Declining plant health could mean increased food prices for already constrained American consumers, experts tell Axios.
Driving the news: It might not be obvious why the health of plants is a contributing factor to food shortages in developed countries. But there's a direct connection — when they're diseased, there's less food to go around, and food prices rise accordingly.
Birth rates increased among women ages 25 and up — especially among those in their mid-to-late-30s — during the second year of the pandemic, according to final data released recently by the CDC's National Center for Health Statistics.
Why it matters: It bucks the trend of declining births almost every year since 2007.
When House Republicans grill Biden administration officials on the COVID-19 response at a Wednesday hearing, some of the sharpest questions may surround how the government oversees research on pathogens that can cause pandemics.
Why it matters: This House Energy and Commerce Committee hearing is part of a series of inquiries planned by the new GOP majority around the pandemic.
